The worst thing about energy drinks is the letdown crash after the kick fades away. Well, Monster Beverage investors know the feeling. Shares of the energy drink company crashed after it posted disappointing quarterly results on Wednesday night.
Pfizer's cancer drug Sutent and Novartis's drug Afinitor have both been found to be effective against the rare form of pancreatic cancer that Apple CEO Steve Jobs was diagnosed with in 2004, according to two studies published in the New England Journal of Medicine.
Twice before, the iconic CEO had to leave the company in others' hands, and if that history is any guide, Apple investors may see the stock price do well once again in his absence -- providing they can handle the pain of the drop long enough to enjoy the recovery.
Soda and processed-food makers insist that all sugars are the same. Yet with studies linking fructose to obesity, diabetes and, most recently, pancreatic cancer, big brands are quietly backing away from using corn-based high-fructose sweetener. Could it eventually become another tobacco-like liability?
